Theriva Biologics, Inc. (TOVX) Capital expenditures 2016–2025
Theriva Biologics, Inc. (TOVX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$35,000FY2025 · since FY2016: $569,000 → $35,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35,000 | +3400.0% |
| FY2024 | $1,000 | -99.5% |
| FY2023 | $202,000 | +74.1% |
| FY2022 | $116,000 | +728.6% |
| FY2021 | $14,000 | +55.6% |
| FY2020 | $9,000 | — |
| FY2019 | $0 | -100.0% |
| FY2018 | $7,000 | -96.7% |
| FY2017 | $212,000 | -62.7% |
| FY2016 | $569,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice